Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs). It develops ...

Thalassemia is a category of inherited blood disorders, becoming a primary health threat due to its increased prevalence worldwide. Through examination and testing of Thalassemia is widely accessible ...